Regulatory actions reaching the register, 27 September to 4 October 2026
5 actions from 2 markets arrived here in this period. Counted, not characterised.
Between 27 September and 4 October 2026, 5 regulatory actions from 2 authorities reached this register: 4 from SAHPRA and 1 from EDA.
None of them was published in this period: all 5 are earlier notices captured now, as this register fills in its back catalogue. A count of what arrived is not a count of what happened.
By kind: recall (4), public warning (1). None of them names a batch or lot number.
This counts what reached the register, not what was published. Where an authority publishes somewhere we cannot read, or in a form we cannot yet parse, it does not appear above — the coverage matrix says where those gaps are, by country.
Every action below links to the issuing authority's own notice.
- EPOETIN 4000 IU vialEDA · DEA-EG-2026-0088
- Direxion™ and Direxion HI-FLO™MicrocathetersSAHPRA · DEA-ZA-2026-44350554
- Complementary Medicines (Multiple products)SAHPRA · DEA-ZA-2026-56896521
- Eribulin DRL (Eribulin Mesylate)SAHPRA · DEA-ZA-2026-75300673
- Ciplavasc 5 (Amlodipine besylate 5mg)SAHPRA · DEA-ZA-2026-80506860
Published regulatory actions, held on this register. Citing one here does not alter it.